Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Memory ASP · Server Demand · Earnings Upgrades / 2026-03-31 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Hypothetical SDC Stake Monetization · North American ESS Acceleration · Valuation Appeal / 2026-01-19 Research
  • [Research] SK hynix (000660 / SKHY) – SK Securities | Supply Tightness · LTA · Shareholder Returns / 2026-07-30 Research
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | Agentic AI · Memory Demand · Cycle Stability / 2026-05-13 Research
  • [Research] Alteogen (196170) – Hana Securities | Exclusive Biogen Licensing Deal · ~USD 40M Q1 Cumulative Upfronts · Rich Q2 Catalysts Ahead / 2026-03-26 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Supply Discipline · LTA · Shareholder Returns / 2026-07-30 Research
  • [Research] Celltrion (068270) – Daishin Securities | New Product Mix · H2 Margin Expansion · New Drug Pipeline / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Solidigm Monetization · Shareholder Returns · Valuation Appeal / 2026-08-11 Research

[Research] Samsung SDI (006400) – Hana Securities | Plant Utilization Recovery · North America ESS Demand · Valuation Re-rating / 2026-04-29

Posted on April 29, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : Hana Securities

Analyst : Hyun-soo Kim, Ji-won Hong (RA)

Investment Rating : BUY (Maintained)

Target Price : KRW 857,000 (Raised)

Core Momentum : Narrowing quarterly operating losses backed by rising Hungarian plant utilization and surging North American power-grid ESS demand, driving upward revisions for 2028 earnings and valuation multiple expansion.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: BUY (Maintained), Target Price KRW 857,000 (Raised by applying a multiple approaching the upper end of historical earnings-growth cycle P/E ranges to 2028F controlling net profit of KRW 2.0 Trillion)
  • Market Data (As of 2026-04-28): Current Price KRW 680,000, Market Cap KRW 54.80 Trillion, KOSPI 6,641.02pt, Shares Outstanding 80,585.5 Thousand, Foreign Ownership 25.35%
  • Key Financial Forecasts (2025 → 2026E → 2027E):
    • Revenue: KRW 13.27 Trillion → KRW 15.70 Trillion → KRW 18.72 Trillion
    • Operating Profit: KRW -1.72 Trillion → KRW -105.6 Billion (Loss Narrowed) → KRW 1.25 Trillion (Turnaround)
    • Pre-tax Profit: KRW -1.36 Trillion → KRW 532.3 Billion (Turnaround) → KRW 1.85 Trillion
    • Net Profit: KRW -649.5 Billion → KRW 353.4 Billion (Turnaround) → KRW 1.30 Trillion
    • EPS: KRW -8,325 → KRW 4,299 (Turnaround) → KRW 15,785
    • ROE: -3.2% → 1.63% → 5.78%
    • PER / PBR: -32.37x / 1.02x → 158.18x / 2.52x → 43.08x / 2.38x
    • EV/EBITDA: 314.44x → 41.46x → 29.54x

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Earnings Review: Revenue reached KRW 3.6 Trillion (YoY +13%, QoQ -7%) and Operating Loss came in at KRW -155.6 Billion (Loss continued YoY/QoQ), narrowing losses by KRW 143.6 Billion QoQ. Mid-to-large EV margins improved (OPM -9.4%, QoQ +5.4%p) supported by AMPC recognition and OEM compensation on US Stellantis JV output shipped to Europe. ESS revenue fell temporarily (-9% QoQ) due to workforce reallocation to Europe, but OPM reached 7.1% (including AMPC) as 4Q25 one-off costs subsided and US utilization rose.
  • 2Q26 Earnings Outlook: Projected Revenue of KRW 3.6 Trillion (YoY +13%, QoQ +1%) and Operating Loss of KRW -65.0 Billion (QoQ loss narrowed by KRW 90.6 Billion), marking a third consecutive quarter of loss reductions supported by fixed-cost dilution and ESS volume recovery.
  • Medium- to Long-Term Drivers & Valuation Re-rating:
    • EV Utilization Recovery: Following a ~20% capacity reduction in Europe over the past three years to lower fixed costs, Hungarian plant utilization is projected to climb from ~50% currently to over 80% by 2027, propelled by new Hyundai model rollouts in 2H26, BMW in 2027, and Mercedes-Benz in 2028.
    • North American Grid ESS Expansion: 2028 annual ESS shipments are projected at 35GWh (23GWh eligible for AMPC). Full-year 2028 earnings estimates are revised upward by 30% on surging US power grid demand.
    • Valuation Multiple Re-rating: Valuation discounts relative to LG Energy Solution are expected to narrow as capacity expansion plans gain clarity alongside the potential monetization process of the Samsung Display (SDC) stake.

📝 Editor’s Comment (Perspective)

The analyst views Samsung SDI not as a short-lived technical rebound story like 2024, but as a fundamentally grounded turnaround battery manufacturer achieving simultaneous improvements in earnings and valuation multiples through European fixed-cost rationalization, rising factory utilization (from ~50% to over 80% by 2027), and accelerating North American grid ESS shipments. This perspective places primary importance on the structural growth of ESS addressing US power shortages and the narrowing of valuation discounts via SDC stake monetization, rather than near-term quarterly operating losses.

To assess the continuing validity of this investment thesis, key monitoring variables include the trajectory of Hungarian plant utilization toward the 80%+ level by 2027 driven by new OEM product cycles (Hyundai, BMW, Mercedes-Benz), the progression of North American ESS shipments toward the 35GWh target for 2028, and concrete operational milestones regarding the SDC stake monetization process to support medium-term capacity additions. These developments can be tracked through upcoming quarterly financial disclosures, IR presentations, and statutory regulatory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, EV & Battery

Post navigation

Previous Post: [Research] Samsung SDI (006400) – DS Investment & Securities | 4Q Turnaround Visibility · Non-PFE LFP ESS · European Volume Models / 2026-04-29
Next Post: [Research] Samsung SDI (006400) – Mirae Asset Securities | SDC Stake Monetization Pursuit · North America ESS & Europe EV Order Acceleration · Operating Profit Turnaround / 2026-04-29

Related Posts

  • [Research] LigaChem Biosciences (141080) – Mirae Asset Securities | Clinical Milestones · Commercialization Potential · Platform PoC / 2025-05-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – Kiwoom Securities | Non-Commodity Shift · Structural Shortage · Price Cycle / 2026-07-31 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 3Q25 Review · Secured Growth Materialization · Expanding Export Share / 2025-11-07 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing Resilience · Earnings Visibility · Valuation Appeal / 2026-04-01 Research
  • [Research] Celltrion (068270) – Mirae Asset Securities | New Product Mix Expansion · In-House Cost Efficiency · Valuation vs Peers / 2026-07-28 Research
  • [Research] Samsung Biologics (207940) – Shinhan Securities | Capacity Expansion · Peptide Entry · Guidance Upgrade / 2026-07-24 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Expanding North American ESS Momentum · Sole Non-China Prismatic Maker · 4Q In Line / 2026-02-03 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | 1Q Trough Passing · ESS Utilization Gains · Humanoid Client Expansion / 2026-03-30 Research
  • [Research] SK hynix (000660 / SKHY) – SK Securities | Supply Tightness · LTA · Shareholder Returns / 2026-07-30 Research
  • [Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Demand · Supply Tightness · Margin Expansion / 2026-08-11 Research
  • [IR] SK hynix (000660 / SKHY) – Q3 2025 Earnings Presentation / 2025-10-29 IR Room
  • [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Surprise · Cost & Incentive Factors · Earnings Volatility / 2026-07-28 Research
  • [Research] Samsung Electro-Mechanics (009150) – Kyobo Securities | AI Server Demand · High-Value Mix · Structural Profitability / 2026-07-31 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme